American Academy of Sleep Medicine

Home American Academy of Sleep Medicine

New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep

Read More

Health

Compassionate Workplace Strategies for Grief Management

3 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Empowering Women: ADPHC's HPV Vaccine Awareness Drive

3 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Future of Healthcare: Dr. Jepsen's Bold Tech Vision

5 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Haya's Kitchen: Reviving Palestinian Culinary Heritage

5 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Winter Stomach Flu: Contagious and Increasing Cases in the

6 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Sports

Messi's Argentina Triumphs in Historic Clash with Brazil

5 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

The Impact of Technology on Sports: Changing the Game

5 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented

Babar Azam resigns as Pakistan captain

5 months   ago

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented